APRE
NASDAQ
US
Aprea Therapeutics, Inc. - Common Stock
$0.72
▲ +$0.01
(+1.56%)
Vol 109K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$6.0M
ROE
-82.4%
Margin
-2670.6%
D/E
0.00
Beta
-1.75
52W
$1–$5
Wall Street Consensus
9 analysts · Apr 20263
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%
Next Report
May 12, 2026
EPS Estimate: $-0.22
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.22 | — | — |
| Dec 2025 | $-0.40 | $-0.32 | +$0.08 |
| Sep 2025 | $-0.35 | $-0.47 | $-0.12 |
| Jun 2025 | $-0.76 | $-0.53 | +$0.23 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -74.2% | -74.0% | -74.2% | -74.2% | -82.4% | -82.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -2742.2% | -1646.8% | -1646.4% | -1646.4% | -2670.6% | -2670.6% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.34 | 5.34 | 5.34 | 5.34 | 5.20 | 5.20 |
Key Ratios
ROA (TTM)
-68.8%
P/S (TTM)
12.22
P/B
0.9
EPS (TTM)
$-2.14
CF/Share
$-3.97
52W High
$5.00
52W Low
$0.90
$0.90
52-Week Range
$5.00
How does APRE compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
APRE valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
12.2
▼
5%
below
peers
(12.9)
vs Peers
vs Industry
Fair value
P/B ratio
0.9
▼
65%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
APRE profitability vs Biotechnology peers
ROE
-82.4%
▼
22%
below
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-2670.6%
▼
831%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-68.8%
▼
47%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
APRE financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.2
▲
17%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
-1.8
▼
280%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
APRE fundamentals radar
APRE
Peer median
Industry
APRE profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
APRE vs peers: key metrics
Latest News
No related news yet